Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Autolus Therapeutics (AUTL) Shares Outstanding (2017 - 2025)

Autolus Therapeutics' Shares Outstanding history spans 9 years, with the latest figure at $34425.0 for Q2 2025.

  • For Q2 2025, Shares Outstanding rose 3442400.0% year-over-year to $34425.0; the TTM value through Jun 2025 reached $34425.0, up 3442400.0%, while the annual FY2024 figure was $88.9 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $88.9 million in Q2 2025 per AUTL's latest filing, up from $34425.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $266.1 million in Q4 2024 to a low of $1.0 in Q1 2023.
  • Average Shares Outstanding over 5 years is $88.7 million, with a median of $88.9 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: plummeted 100.0% in 2024, then surged 3442400.0% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $90.9 million in 2021, then tumbled by 99.96% to $34425.0 in 2022, then soared by 258123.81% to $88.9 million in 2023, then changed by 0.0% to $88.9 million in 2024, then tumbled by 99.96% to $34425.0 in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Shares Outstanding are $34425.0 (Q2 2025), $34425.0 (Q1 2025), and $88.9 million (Q4 2024).